Cargando…

A Crimean-Congo hemorrhagic fever (CCHF) viral vaccine expressing nucleoprotein is immunogenic but fails to confer protection against lethal disease

Crimean-Congo Hemorrhagic Fever (CCHF) is a severe tick-borne disease, endemic in many countries in Africa, the Middle East, Eastern Europe and Asia. Between 15–70% of reported cases are fatal with no approved vaccine available. In the present study, the attenuated poxvirus vector, Modified Vaccinia...

Descripción completa

Detalles Bibliográficos
Autores principales: Dowall, SD, Buttigieg, KR, Findlay-Wilson, SJD, Rayner, E, Pearson, G, Miloszewska, A, Graham, VA, Carroll, MW, Hewson, R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5049717/
https://www.ncbi.nlm.nih.gov/pubmed/26309231
http://dx.doi.org/10.1080/21645515.2015.1078045
_version_ 1782457768163147776
author Dowall, SD
Buttigieg, KR
Findlay-Wilson, SJD
Rayner, E
Pearson, G
Miloszewska, A
Graham, VA
Carroll, MW
Hewson, R
author_facet Dowall, SD
Buttigieg, KR
Findlay-Wilson, SJD
Rayner, E
Pearson, G
Miloszewska, A
Graham, VA
Carroll, MW
Hewson, R
author_sort Dowall, SD
collection PubMed
description Crimean-Congo Hemorrhagic Fever (CCHF) is a severe tick-borne disease, endemic in many countries in Africa, the Middle East, Eastern Europe and Asia. Between 15–70% of reported cases are fatal with no approved vaccine available. In the present study, the attenuated poxvirus vector, Modified Vaccinia virus Ankara, was used to develop a recombinant candidate vaccine expressing the CCHF virus nucleoprotein. Cellular and humoral immunogenicity was confirmed in 2 mouse strains, including type I interferon receptor knockout mice, which are susceptible to CCHF disease. Despite the immune responses generated post-immunisation, the vaccine failed to protect animals from lethal disease in a challenge model.
format Online
Article
Text
id pubmed-5049717
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-50497172016-10-12 A Crimean-Congo hemorrhagic fever (CCHF) viral vaccine expressing nucleoprotein is immunogenic but fails to confer protection against lethal disease Dowall, SD Buttigieg, KR Findlay-Wilson, SJD Rayner, E Pearson, G Miloszewska, A Graham, VA Carroll, MW Hewson, R Hum Vaccin Immunother Research Papers Crimean-Congo Hemorrhagic Fever (CCHF) is a severe tick-borne disease, endemic in many countries in Africa, the Middle East, Eastern Europe and Asia. Between 15–70% of reported cases are fatal with no approved vaccine available. In the present study, the attenuated poxvirus vector, Modified Vaccinia virus Ankara, was used to develop a recombinant candidate vaccine expressing the CCHF virus nucleoprotein. Cellular and humoral immunogenicity was confirmed in 2 mouse strains, including type I interferon receptor knockout mice, which are susceptible to CCHF disease. Despite the immune responses generated post-immunisation, the vaccine failed to protect animals from lethal disease in a challenge model. Taylor & Francis 2015-08-26 /pmc/articles/PMC5049717/ /pubmed/26309231 http://dx.doi.org/10.1080/21645515.2015.1078045 Text en © 2016 The Author(s). Published with license by Taylor & Francis Group, LLC http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The moral rights of the named author(s) have been asserted.
spellingShingle Research Papers
Dowall, SD
Buttigieg, KR
Findlay-Wilson, SJD
Rayner, E
Pearson, G
Miloszewska, A
Graham, VA
Carroll, MW
Hewson, R
A Crimean-Congo hemorrhagic fever (CCHF) viral vaccine expressing nucleoprotein is immunogenic but fails to confer protection against lethal disease
title A Crimean-Congo hemorrhagic fever (CCHF) viral vaccine expressing nucleoprotein is immunogenic but fails to confer protection against lethal disease
title_full A Crimean-Congo hemorrhagic fever (CCHF) viral vaccine expressing nucleoprotein is immunogenic but fails to confer protection against lethal disease
title_fullStr A Crimean-Congo hemorrhagic fever (CCHF) viral vaccine expressing nucleoprotein is immunogenic but fails to confer protection against lethal disease
title_full_unstemmed A Crimean-Congo hemorrhagic fever (CCHF) viral vaccine expressing nucleoprotein is immunogenic but fails to confer protection against lethal disease
title_short A Crimean-Congo hemorrhagic fever (CCHF) viral vaccine expressing nucleoprotein is immunogenic but fails to confer protection against lethal disease
title_sort crimean-congo hemorrhagic fever (cchf) viral vaccine expressing nucleoprotein is immunogenic but fails to confer protection against lethal disease
topic Research Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5049717/
https://www.ncbi.nlm.nih.gov/pubmed/26309231
http://dx.doi.org/10.1080/21645515.2015.1078045
work_keys_str_mv AT dowallsd acrimeancongohemorrhagicfevercchfviralvaccineexpressingnucleoproteinisimmunogenicbutfailstoconferprotectionagainstlethaldisease
AT buttigiegkr acrimeancongohemorrhagicfevercchfviralvaccineexpressingnucleoproteinisimmunogenicbutfailstoconferprotectionagainstlethaldisease
AT findlaywilsonsjd acrimeancongohemorrhagicfevercchfviralvaccineexpressingnucleoproteinisimmunogenicbutfailstoconferprotectionagainstlethaldisease
AT raynere acrimeancongohemorrhagicfevercchfviralvaccineexpressingnucleoproteinisimmunogenicbutfailstoconferprotectionagainstlethaldisease
AT pearsong acrimeancongohemorrhagicfevercchfviralvaccineexpressingnucleoproteinisimmunogenicbutfailstoconferprotectionagainstlethaldisease
AT miloszewskaa acrimeancongohemorrhagicfevercchfviralvaccineexpressingnucleoproteinisimmunogenicbutfailstoconferprotectionagainstlethaldisease
AT grahamva acrimeancongohemorrhagicfevercchfviralvaccineexpressingnucleoproteinisimmunogenicbutfailstoconferprotectionagainstlethaldisease
AT carrollmw acrimeancongohemorrhagicfevercchfviralvaccineexpressingnucleoproteinisimmunogenicbutfailstoconferprotectionagainstlethaldisease
AT hewsonr acrimeancongohemorrhagicfevercchfviralvaccineexpressingnucleoproteinisimmunogenicbutfailstoconferprotectionagainstlethaldisease
AT dowallsd crimeancongohemorrhagicfevercchfviralvaccineexpressingnucleoproteinisimmunogenicbutfailstoconferprotectionagainstlethaldisease
AT buttigiegkr crimeancongohemorrhagicfevercchfviralvaccineexpressingnucleoproteinisimmunogenicbutfailstoconferprotectionagainstlethaldisease
AT findlaywilsonsjd crimeancongohemorrhagicfevercchfviralvaccineexpressingnucleoproteinisimmunogenicbutfailstoconferprotectionagainstlethaldisease
AT raynere crimeancongohemorrhagicfevercchfviralvaccineexpressingnucleoproteinisimmunogenicbutfailstoconferprotectionagainstlethaldisease
AT pearsong crimeancongohemorrhagicfevercchfviralvaccineexpressingnucleoproteinisimmunogenicbutfailstoconferprotectionagainstlethaldisease
AT miloszewskaa crimeancongohemorrhagicfevercchfviralvaccineexpressingnucleoproteinisimmunogenicbutfailstoconferprotectionagainstlethaldisease
AT grahamva crimeancongohemorrhagicfevercchfviralvaccineexpressingnucleoproteinisimmunogenicbutfailstoconferprotectionagainstlethaldisease
AT carrollmw crimeancongohemorrhagicfevercchfviralvaccineexpressingnucleoproteinisimmunogenicbutfailstoconferprotectionagainstlethaldisease
AT hewsonr crimeancongohemorrhagicfevercchfviralvaccineexpressingnucleoproteinisimmunogenicbutfailstoconferprotectionagainstlethaldisease